Diabetes hardware company embecta aims to look beyond insulin and reshape itself into a more varied drug delivery provider—and it’s kick-starting that effort with the acquisition of a global ...
This strategic move brings stability to Embecta, addressing challenges faced since its spin-off from Becton Dickinson & Co.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results